Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment

Abstract

Glioblastoma (GBM) is the most frequent and aggressive primary tumor of the brain and averages a life expectancy in diagnosed patients of only 15 months. Hence, more effective therapies against this malignancy are urgently needed. Several diseases, including cancer, are featured by high levels of reactive oxygen species (ROS), which are possible GBM hallmarks to target or benefit from. Therefore, the covalent linkage of drugs to ROS-responsive molecules can be exploited aiming for a selective drug release within relevant pathological environments. In this work, we designed a new ROS-responsive prodrug by using Melphalan (MPH) covalently coupled with methoxy polyethylene glycol (mPEG) through a ROS-cleavable group thioketal (TK), demonstrating the capacity to self-assembly into nanosized micelles. Full chemical-physical characterization was conducted on the polymeric-prodrug and proper controls, along with in vitro cytotoxicity assayed on different GBM cell lines and "healthy" astrocyte cells confirming the absence of any cytotoxicity of the prodrug on healthy cells (i.e. astrocytes). These results were compared with the non-ROS responsive counterpart, underlining the anti-tumoral activity of ROS-responsive compared to the non-ROSresponsive prodrug on GBM cells expressing high levels of ROS. On the other hand, the combination treatment with this ROS-responsive prodrug and X-ray irradiation on human GBM cells resulted in an increase of the antitumoral effect, and this might be connected to radiotherapy. Hence, these results represent a starting point for a rationale design of innovative and tailored ROS-responsive prodrugs to be used in GBM therapy and in combination with radiotherapy.

WITHDRAWN: High SLC7A11 Expression Is Correlated With Poor Prognosis and Associated With Ferroptosis in Ovarian Cancer 

“…Numerous basic and clinical studies have found that the level of lipid reactive oxygen species in tumor cells is higher than that of normal cells [26,27].Recently, ferroptosis, which involves lipid reactive oxygen species, has been proposed to be a potential therapeutic target for cancer [28].…”

Tween® Preserves Enzyme Activity and Stability in PLGA Nanoparticles

“…To overcome these problems, the idea of enzyme encapsulation into tailored nanoparticles (NPs) represents one of the most attractive strategies. Among current advances in developed NPs, polymer-based NPs have gained increasing attention as biocompatible, biodegradable, targeted, and versatile platforms [14][15][16][17][18][19][20] for the delivery of a wide array of therapeutic molecules ranging from small molecules [21][22][23][24], peptides [25][26][27][28], proteins and enzymes [2,4,[29][30][31], and genetic material [32][33][34]. The encapsulation of enzymes into polymeric NPs offer several advantages compared to conventional enzyme-based therapy, including: (i) stabilizing and protecting the enzyme; (ii) improving biological activity; (iii) possibility of targeted delivery; (iv) controlling the enzyme release kinetics; (v) improving therapeutic efficacy and safety [10,35,36].…”

Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines

“…Prodrugs are inactive precursors of a drug designed to increase the amount of drug converted to its active form by a certain pathological or biological stimulus [40][41][42]. With the prodrug idea in mind, ROS-sensitive TK linkers have been exploited to conjugate a drug to another drug or polymer that can then self-assemble into NPs [43]. Once the prodrug NPs reach the diseased tissues, the high concentration of ROS cleaves the TK linker to release and activate the drug (Figure 2b).…”